Abstract
Virtual ligand screening is a powerful technique to identify potential hits of targets and to increase hit rates. Here, we describe how we used this technique combined with NMR 15N HSQC experiments to obtain small molecules that bind to the PDZ domain of Dvl targeting the Wnt signaling pathway.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Wong H-C, et al. Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the c-terminal region of Frizzled. Mol Cell. 2003;12:1251–60.
Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov. 2006;5:997–1014.
Grandy D, et al. Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled. J Biol Chem. 2009; 284:16256–63.
Lee HJ, et al. Sulindac inhibits canonical Wnt signaling by blocking the PDZ domain of the protein Dishevelled. Angew Chem Int Ed Engl. 2009;48:6448–52.
Lee HJ, Zheng JJ. PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun Signal. 2010;8:8.
Cheyette BNR, et al. Dapper, a Dishevelled-associated antagonist of b-Catenin and JNK signaling, is required for Notochord formation. Dev Cell. 2002;2:449–61.
Gohlke H, Case DA. Converging free energy estimates: MM-PB(GB)SA studies on the protein–protein complex Ras–Raf. J Comput Chem. 2004;25:238–50.
Wang J, et al. Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. J Am Chem Soc. 2001;123:5221–30.
Wang W, et al. BIOMOLECULAR SIMULATIONS: Recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions. Annu Rev Biophys Biomol Struct. 2001;30:211–43.
Burbaum JJ, Sigal NH. New technologies for high-throughput screening. Curr Opin Chem Biol. 1997;1:72–8.
Liu B, et al. Technological advances in high-throughput screening. Am J Pharmacogenomics. 2004;4:263–76.
Bleicher KH, et al. Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov. 2003;2:369–78.
Keseru GM, Makara GM. Hit discovery and hit-to-lead approaches. Drug Discov Today. 2006;11:741–8.
Irwin JJ, Shoichet BK. ZINC—a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2004; 45:177–82.
Hann MM, Oprea TI. Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol. 2004;8:255–63.
Shan J, et al. Identification of a specific inhibitor of the Dishevelled PDZ domain. Biochemistry. 2005;44:15495–503.
London TBC, et al. Interaction between the internal motif KTXXXI of Idax and mDvl PDZ domain. Biochem Biophys Res Commun. 2004;322:326–32.
Hurst T. Flexible 3D searching: the directed tweak technique. J Chem Inf Comput Sci. 1994;34:190–6.
Rarey M, et al. A fast flexible docking method using an incremental construction algorithm. J Mol Biol. 1996;261:470–89.
Clark RD, et al. Consensus scoring for ligand/protein interactions. J Mol Graph Model. 2002;20:281–95.
Zheng J, et al. Identification of the binding site for acidic phospholipids on the PH domain of dynamin: Implications for stimulation of GTPase activity. J Mol Biol. 1996;255:14–21.
Delaglio F, et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995;6:277–93.
Goddard TD, Kenller DG SPARKY 3. University of California, San Francisco 2008.
Worrall JAR, et al. Transient protein interactions studied by NMR spectroscopy: the case of cytochrome c and adrenodoxin. Biochemistry. 2003;42:7068–76.
Case DA, et al. AMBER 8. La Jolla: Scripps Research Institute; 2004.
Wang J, et al. Development and testing of a general amber force field. J Comput Chem. 2004;25:1157–74.
Cornell WD, et al. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc. 1995;117:5179–97.
Cerutti DS, et al. Staggered Mesh Ewald: an extension of the Smooth Particle-Mesh Ewald method adding great versatility. J Chem Theory Comput. 2009;5:2322.
Simmerling C, et al. Combined locally enhanced sampling and Particle Mesh Ewald as a strategy to locate the experimental structure of a nonhelical nucleic acid. J Am Chem Soc. 1998;120:7149–55.
Gohlke H, et al. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J Mol Biol. 2003; 330:891–913.
Kollman PA, et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res. 2000;33:889–97.
Gund P. Three-dimensional pharmacophoric pattern searching. Prog Mol Subcell Biol. 1977;5:17.
Guner OF. Pharmacophore perception, development, and use in drug design. La Jolla: International University Line; 2000.
Langer T, Hoffmann RD. Pharmacophores and pharmacophore searches. Wiley: Weinheim; 2006.
Wolber G, Langer T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model. 2004;45:160–9.
Friesner RA, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47:1739–49.
Long J-F, et al. Supramodular structure and synergistic target binding of the N-terminal tandem PDZ domains of PSD-95. J Mol Biol. 2003;327:203–14.
Feng W, et al. PDZ7 of glutamate receptor interacting protein binds to its target via a novel hydrophobic surface area. J Biol Chem. 2002;277:41140–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this protocol
Cite this protocol
Shan, J., Zheng, J.J. (2012). Virtual Ligand Screening Combined with NMR to Identify Dvl PDZ Domain Inhibitors Targeting the Wnt Signaling. In: Zheng, Y. (eds) Rational Drug Design. Methods in Molecular Biology, vol 928. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-008-3_2
Download citation
DOI: https://doi.org/10.1007/978-1-62703-008-3_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-007-6
Online ISBN: 978-1-62703-008-3
eBook Packages: Springer Protocols